- Home
- HKIT vs ONCO Comparison
HKIT vs ONCO Comparison
Compare HKIT & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | ONCO |
|---|---|---|
| Founded | 1996 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 725.9K | 755.3K |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HKIT | ONCO |
|---|---|---|
| Price | $0.82 | $0.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.0M | 13.3M |
| Earning Date | 04-24-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $815,371.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.03 | $0.07 |
| 52 Week High | $4.21 | $7.65 |
Technical Indicators
Market Signals| Indicator | HKIT | ONCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 44.32 |
| Support Level | $0.53 | $0.62 |
| Resistance Level | $2.08 | $0.95 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 7.52 | 18.86 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.